Patents Assigned to Respicardia, Inc.
-
Patent number: 11883659Abstract: A means for treating breathing disorders by stimulating respiratory muscles or nerves to entrain respiratory systems while leaving respiratory drive intact. Embodiments of the invention employ frequency analysis to determine if appropriate stimulation energy is being applied.Type: GrantFiled: June 17, 2021Date of Patent: January 30, 2024Assignee: ZOLL RESPICARDIA, INC.Inventors: Mark Gelfand, Kristofer J. James, Randy W. Westlund, Antonios Panteleon, Todd P. Goblish, Mark C. Lynn
-
Patent number: 11865333Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen or lumen and to provide feedback to lead implanters.Type: GrantFiled: June 17, 2022Date of Patent: January 9, 2024Assignee: ZOLL RESPICARDIA, INC.Inventor: Randy W. Westlund
-
Publication number: 20220248978Abstract: Some examples of the disclosure include applications, treatment-monitoring systems and computing devices configured with the applications, and computer-implemented methods to aid user monitoring of disordered-breathing and treatment.Type: ApplicationFiled: February 10, 2022Publication date: August 11, 2022Applicant: ZOLL RESPICARDIA, INC.Inventors: Antonis Panteleon, Kristofer J. James, Todd P. Goblish
-
Patent number: 11389648Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen or lumen and to provide feedback to lead implanters.Type: GrantFiled: December 17, 2019Date of Patent: July 19, 2022Assignee: ZOLL RESPICARDIA, INC.Inventor: Randy W. Westlund
-
Patent number: 11305114Abstract: A system for treating disordered breathing of a human being includes an implantable transvenous stimulation lead having at least one stimulation electrode and a sensor configured to detect activity level of the human being. The system includes an energy source, a pulse generator and circuitry, the circuitry operative to receive a signal indicative of the activity level of the human being from the sensor, wherein the circuitry is configured to cause the energy source and the pulse generator to deliver spaced apart stimulation signals to the at least one stimulation electrode while the activity level of the human being is sufficiently low to be indicative of sleep. Spaced apart stimulation pulses from the electrode are configured to extend a duration of a time of at least one breath being defined as the time from an onset of inhalation to the onset of inhalation of a successive breath.Type: GrantFiled: May 21, 2018Date of Patent: April 19, 2022Assignee: ZOLL RESPICARDIA, INC.Inventors: Mark Gelfand, Howard Levin, Andrew Halpert, Antonis Panteleon
-
Patent number: 11305119Abstract: An implantable medical device for treating breathing disorders such as central sleep apnea wherein stimulation is provided to the phrenic never through a transvenous lead system with the stimulation beginning after inspiration to extend the duration of a breath and to hold the diaphragm in a contracted condition.Type: GrantFiled: May 18, 2015Date of Patent: April 19, 2022Assignee: ZOLL RESPICARDIA, INC.Inventors: Mark Gelfand, Howard R. Levin, Andrew Halpert
-
Patent number: 11305111Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen and to orient electrodes in a preferred orientation.Type: GrantFiled: November 20, 2019Date of Patent: April 19, 2022Assignee: ZOLL RESPICARDIA, INC.Inventors: Randy W. Westlund, Mark C. Lynn
-
Patent number: 11065443Abstract: A means for treating breathing disorders by stimulating respiratory muscles or nerves to entrain respiratory systems while leaving respiratory drive intact. Embodiments of the invention employ frequency analysis to determine if appropriate stimulation energy is being applied.Type: GrantFiled: June 7, 2018Date of Patent: July 20, 2021Assignee: Zoll Respicardia, Inc.Inventors: Mark Gelfand, Kristofer J. James, Randy W. Westlund, Antonis Panteleon, Todd P. Goblish, Mark C. Lynn
-
Patent number: 10821280Abstract: A lead for navigating small vessels and a catheter system for implantation of leads into small vessels. Veins that return blood to the heart against the force of gravity often have valves in them to prevent backflow of deoxygenated blood. Leads and catheter systems in accordance with embodiments of the invention allow cannulation and lead implantation in small, tortuous, obstructed, and difficult to access veins enabling a range of stimulation and sensing applications.Type: GrantFiled: July 28, 2017Date of Patent: November 3, 2020Assignee: Respicardia, Inc.Inventors: Randy W. Westlund, Mark C. Lynn
-
Patent number: 10603491Abstract: Detection and treatment of disordered breathing is disclosed, with treatment being primarily delivered using electrical stimulation of the diaphragm, either directly or by stimulating appropriate nerves.Type: GrantFiled: May 18, 2015Date of Patent: March 31, 2020Assignee: Respicardia, Inc.Inventors: Mark Gelfand, Howard R. Levin, Andrew Halpert, Antonis Panteleon
-
Patent number: 10543363Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen or lumen and to provide feedback to lead implanters.Type: GrantFiled: November 6, 2015Date of Patent: January 28, 2020Assignee: RESPICARDIA, INC.Inventor: Randy W. Westlund
-
Patent number: 10518090Abstract: An implantable medical device for treating breathing disorders such as central sleep apnea wherein stimulation is provided to the phrenic never through a transvenous lead system with the stimulation beginning after inspiration to extend the duration of a breath and to hold the diaphragm in a contracted condition.Type: GrantFiled: June 29, 2012Date of Patent: December 31, 2019Assignee: RESPICARDIA, INC.Inventors: Mark Gelfand, Howard R. Levin, Andrew Halpert
-
Patent number: 10507322Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen and to orient electrodes in a preferred orientation.Type: GrantFiled: October 3, 2016Date of Patent: December 17, 2019Assignee: RESPICARDIA, INC.Inventors: Randy W. Westlund, Mark C. Lynn
-
Patent number: 10406366Abstract: A lead system and method of use for treating breathing disorders by the transvenous stimulation of the phrenic nerve. The lead is implanted in a vein near one portion of the phrenic nerve.Type: GrantFiled: April 30, 2008Date of Patent: September 10, 2019Assignee: RESPICARDIA, INC.Inventors: Randy W. Westlund, Mark Gelfand
-
Patent number: 10300270Abstract: The present invention is related to an implantable medical device for treating breathing disorders and cardiac disorders by delivering stimulation energy to the phrenic nerve, hypoglossal nerves and cardiac muscle tissues.Type: GrantFiled: July 31, 2017Date of Patent: May 28, 2019Assignee: Respicardia, Inc.Inventors: Mark Gelfand, Howard R. Levin
-
Patent number: 9999768Abstract: A means for treating breathing disorders by stimulating respiratory muscles or nerves to entrain respiratory systems while leaving respiratory drive intact. Embodiments of the invention employ frequency analysis to determine if appropriate stimulation energy is being applied.Type: GrantFiled: June 21, 2012Date of Patent: June 19, 2018Assignee: Respicardia, Inc.Inventors: Mark Gelfand, Kristofer J. James, Randy W. Westlund, Antonis Panteleon, Todd P. Goblish, Mark C. Lynn
-
Patent number: 9987488Abstract: Detection and treatment of disordered breathing, with treatment being primarily delivered using electrical stimulation of the diaphragm, either directly or by stimulating appropriate nerves. In some embodiments, the stimulus is applied to still at least one lung upon detection of an apnea-hypopnea of some length or upon the detection of hyperpnea. The stimulation may be initiated during the apnea-hypopnea period or upon detection of a breath of a predetermined intensity near the end of apnea-hypopnea. The stimulation may be initiated in phase with respiration or irrespective of the phase of respiration.Type: GrantFiled: June 27, 2008Date of Patent: June 5, 2018Assignee: Respicardia, Inc.Inventors: Mark Gelfand, Howard Levin, Andrew Halpert, Antonis Panteleon
-
Patent number: 9744349Abstract: A lead for navigating small vessels and a catheter system for implantation of leads into small vessels. Veins that return blood to the heart against the force of gravity often have valves in them to prevent backflow of deoxygenated blood. Leads and catheter systems in accordance with embodiments of the invention allow cannulation and lead implantation in small, tortuous, obstructed, and difficult to access veins enabling a range of stimulation and sensing applications.Type: GrantFiled: March 16, 2011Date of Patent: August 29, 2017Assignee: Respicardia, Inc.Inventors: Randy W. Westlund, Mark C. Lynn
-
Patent number: 9744351Abstract: The present invention is related to an implantable medical device for treating breathing disorders and cardiac disorders by delivering stimulation energy to the phrenic nerve, hypoglossal nerves and cardiac muscle tissues.Type: GrantFiled: October 23, 2014Date of Patent: August 29, 2017Assignee: Respicardia, Inc.Inventors: Mark Gelfand, Howard R. Levin
-
Patent number: 9468755Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen and to orient electrodes in a preferred orientation.Type: GrantFiled: September 30, 2009Date of Patent: October 18, 2016Assignee: Respicardia, Inc.Inventors: Randy W. Westlund, Mark C. Lynn